TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3893101

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 3837

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3837

Group type: EXPERIMENTAL
Intervention: Physician diagnosis
Number of subjects: 3837

Group type: EXPERIMENTAL
Intervention: Questionnaire
Number of subjects: 3837

Group type: EXPERIMENTAL
Intervention: Physician diagnosis and Questionnaire
Number of subjects: 3837
Study: 29423715

Group type: EXPERIMENTAL
Intervention: zoledronic acid (ZOL)
Number of subjects: 306
Study: 27624507

Group type: EXPERIMENTAL
Intervention: Citywide care coordination program combined with an ED care coordination information system
Number of subjects: 165
Study: 24558403

Group type: EXPERIMENTAL
Intervention: recombinant Canarypox (CP) vaccine vCP205 via inguinal-subcutaneous injection
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: recombinant Canarypox (CP) vaccine vCP205 via deltoid-intramuscular injection
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: recombinant Canarypox (CP) vaccine vCP205
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 22683442

Group type: EXPERIMENTAL
Intervention: Immediate treatment (IT) group, n=11
Number of subjects: 22

Group type: COMPARATOR
Intervention: Waitlist condition (WL) group, n=11
Number of subjects: 22
Study: 20530307

Group type: EXPERIMENTAL
Intervention: Collaborative Management in Pediatrics, a 9‐hour behavior change curriculum based on brief MI plus written feedback on communication skills
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control residents
Number of subjects: 18
Study: 18410863

Group type: EXPERIMENTAL
Intervention: Trapezius squeezing test
Number of subjects: 45
Study: 16765490

Group type: EXPERIMENTAL
Intervention: Priorix
Number of subjects: 295

Group type: COMPARATOR
Intervention: MMR-II
Number of subjects: 295
Study: 12862324

Group type: EXPERIMENTAL
Intervention: Heat stress exposure (55 degrees C, 30% humidity)
Number of subjects: 6
Study: 10950002

Group type: EXPERIMENTAL
Intervention: Internal sphincterotomy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Topical nitroglycerin 0.25% tid
Number of subjects: 90
Study: 8773735

Group type: EXPERIMENTAL
Intervention: 2 whole eggs (E)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 egg yolks (Y)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 egg whites
Number of subjects: 12

Group type: COMPARATOR
Intervention: No eggs (Control)
Number of subjects: 12
Study: 1297887

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nifedipine + Propranolol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nifedipine + Verapamil
Number of subjects: 60
Study: 6338064

Group type: EXPERIMENTAL
Intervention: Sulfur-salicylic acid shampoo
Number of subjects: 38

Group type: COMPARATOR
Intervention: Bland oil-in-water lotion (placebo)
Number of subjects: 38
Study: 31204331

Group type: EXPERIMENTAL
Intervention: Alchornea laxiflora
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Zanthoxylum zanthoxyloides
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anogeissus leocarpus
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Masularia acuminate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-herbal fluoridated toothpaste
Number of subjects: 20
Study: 30938602

Group type: EXPERIMENTAL
Intervention: Interactive computer-based education material (ICB-EM)
Number of subjects: 96

Group type: COMPARATOR
Intervention: British Orthodontic Society (BOS) hypodontia leaflet
Number of subjects: 96
Study: 27036970

Group type: EXPERIMENTAL
Intervention: Online self-help program for people with HIV and depressive symptoms, duration 6 to 10 weeks, with weekly motivational support from a coach.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list-control group receiving minimal support from a coach for 8 weeks.
Number of subjects: 0
Study: 24842985

Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 807

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 807
Study: 22314532

Group type: COMPARATOR
Intervention: GSK2248761 30 mg QD for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: GSK2248761 100 mg QD for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: GSK2248761 200 mg QD for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: GSK2248761 400 mg QD for 7 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: GSK2248761 800 mg QD for 7 days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GSK2248761 (all doses)
Number of subjects: 18
Study: 19596459

Group type: EXPERIMENTAL
Intervention: Multifaceted nutritional intervention (chocolate, homemade oral supplements), group exercise (moderate intensity), and oral care
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study: 17671058

Group type: EXPERIMENTAL
Intervention: Early nasal continuous positive airway pressure preceded by a sustained inflation through a nasopharyngeal tube
Number of subjects: 207

Group type: COMPARATOR
Intervention: Repeated manual inflations with a self‐inflating bag and mask followed by nasal continuous positive airway pressure
Number of subjects: 207
Study: 16249086

Group type: EXPERIMENTAL
Intervention: MRI examinations
Number of subjects: 24
Study: 12075641

Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg/ml
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bupivacaine 5 mg/ml
Number of subjects: 120
Study: 11107573

Group type: COMPARATOR
Intervention: Mild ischemic stroke patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Severe ischemic stroke patients
Number of subjects: 40
Study: 7769797

Group type: EXPERIMENTAL
Intervention: Remikiren 30 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Remikiren 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Remikiren 300 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Remikiren 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Remikiren 1,000 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2155645

Group type: EXPERIMENTAL
Intervention: High intensity chemotherapy (cisplatin 120 mg m‐2 i.v. day 1, cyclophosphamide 1,000 mg‐2 i.v. day 1, given at 21‐day intervals for six cycles)
Number of subjects: 19

Group type: COMPARATOR
Intervention: High intensity chemotherapy
Number of subjects: 19
Study: 6107853

Group type: EXPERIMENTAL
Intervention: Sulfasalazine (1 g three times a day for six weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (0.5 g suppositories three times a day for six weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sulfapyridine (0.5 g three times a day for six weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sulfapyridine
Number of subjects: 32
Study: 30431398

Group type: EXPERIMENTAL
Intervention: Individualised carbohydrate-rich breakfast (BT; 831±67 kcal eaten before 09:00)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No-breakfast (NBT; extended overnight fast until 12:00)
Number of subjects: 10
Study: 27859929

Group type: EXPERIMENTAL
Intervention: Diuretic‐induced isosmotic dehydration to lower SkBF (DEH)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous saline infusion to maintain SkBF (SAL)
Number of subjects: 7
Study: 26471400

Group type: EXPERIMENTAL
Intervention: left dorsolateral prefrontal (DLPF) tDCS
Number of subjects: 21
Study: 23376338

Group type: EXPERIMENTAL
Intervention: CAPP intervention (one-day cognitive behavioral program and three follow-up group sessions)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 31
Study: 20648661

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Conventional dose of vitamin D (880 IU/day)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: High dose of vitamin D (1600 IU/day)
Number of subjects: 113

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 113
Study: 18931099

Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg b.i.d.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 17377114

Group type: EXPERIMENTAL
Intervention: 1% preservative-free 2-chloroprocaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1% lidocaine
Number of subjects: 30
Study: 15472161

Group type: EXPERIMENTAL
Intervention: Hip protectors
Number of subjects: 302
Study: 11452709

Group type: EXPERIMENTAL
Intervention: BAY 12‐9566 (50 mg single oral dose)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: BAY 12‐9566
Number of subjects: 36
Study: 9931887

Group type: EXPERIMENTAL
Intervention: Jejunal pouch interposition between esophagus and duodenum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group not explicitly mentioned)
Number of subjects: 0
Study: 8072252

Group type: EXPERIMENTAL
Intervention: Mechanical thrombolysis (M) using heparinized saline as the pulsing agent
Number of subjects: 103

Group type: COMPARATOR
Intervention: Pharmacomechanical thrombolysis (PM) using concentrated urokinase as the pulsing agent
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Mechanical thrombolysis (M)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Pharmacomechanical thrombolysis (PM)
Number of subjects: 103
Study: 2522475

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide, 60 micrograms by metered-dose inhaler
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sulfur dioxide (SO2) exposure at 0, 0.5, and 1.0 ppm
Number of subjects: 9
Study: 30253985

Group type: EXPERIMENTAL
Intervention: Portable Video Media (PVM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard Verbal Communication (SVC)
Number of subjects: 54
Study: 27730665

Group type: EXPERIMENTAL
Intervention: ACT-389949
Number of subjects: 0
Study: 26700838

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 22963235

Group type: EXPERIMENTAL
Intervention: Higher patient self-efficacy for eating healthy
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Spouse greater perceived support for eating healthy
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Older patient age
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Normal blood pressure
Number of subjects: 255
Study: 21481716

Group type: EXPERIMENTAL
Intervention: Maltitol test drink (50 g)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Glucose test drink (50 g)
Number of subjects: 30
Study: 19656102

Group type: EXPERIMENTAL
Intervention: Intracoronary administration of stem cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (not specified)
Number of subjects: 0
Study: 16917170

Group type: EXPERIMENTAL
Intervention: Intratympanic gentamicin instillation therapy
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Normal vestibular evoked myogenic potentials before therapy
Number of subjects: 6

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 6
Study: 14972474

Group type: EXPERIMENTAL
Intervention: Perioperative antibiotics (cefazolin and ciprofloxacin)
Number of subjects: 517

Group type: COMPARATOR
Intervention: No perioperative antibiotics (control group)
Number of subjects: 517
Study: 11284596

Group type: EXPERIMENTAL
Intervention: Collagen-based composite
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard hemostatic methods (electrocautery and collagen sponge)
Number of subjects: 83
Study: 9134237

Group type: EXPERIMENTAL
Intervention: Test participants
Number of subjects: 528

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 528
Study: 8424024

Group type: EXPERIMENTAL
Intervention: Focal feed between 10 PM and 12 AM, gradual lengthening of nighttime feed intervals, alternative caretaking behaviors, maximizing environmental differences between day and night
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 26
Study: 2820298

Group type: EXPERIMENTAL
Intervention: Zinc gluconate lozenge (23 mg of elemental zinc), administered 8 times per day for 5 days (trial 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc gluconate lozenge (23 mg of elemental zinc), administered 8 times per day for 7 days (trial 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc gluconate lozenge (23 mg of elemental zinc)
Number of subjects: 0
Study: 29696403

Group type: EXPERIMENTAL
Intervention: Guy2Guy text messaging based HIV prevention program
Number of subjects: 302

Group type: COMPARATOR
Intervention: Attention-matched control program
Number of subjects: 302
Study: 27959766

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (25 mg)
Number of subjects: 1959

Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 1959
Study: 24820300

Group type: EXPERIMENTAL
Intervention: Single-site surgery
Number of subjects: 54

Group type: COMPARATOR
Intervention: Three-port surgery
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study: 22385074

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream for 4 weeks before Mohs micrographic surgery (MMS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (MMS only)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream for 4 weeks before MMS
Number of subjects: 70
Study: 20399360

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment (medications, physical therapy, lumbar injection)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical intervention (lumbar discectomy)
Number of subjects: 0
Study: 18339002

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (hiking downwards)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Concentric exercise (hiking upwards)
Number of subjects: 45
Study: 16239154

Group type: EXPERIMENTAL
Intervention: Medication for 5 weeks, followed by combined medication plus CBT for 5 weeks
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combined treatment for 5 weeks, followed by CBT alone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: CBT alone
Number of subjects: 17
Study: 11940259

Group type: EXPERIMENTAL
Intervention: High quality research evidence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Translational barriers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emerging therapies in critical care
Number of subjects: 0
Study: 10862229

Group type: EXPERIMENTAL
Intervention: Intervention group (determination of baseline CK level, CK MB fraction, cTnI level, and myoglobin level at baseline and at 2 hours)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Control group (determination of baseline CK level and CK MB fraction)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 296
Study: 9505999

Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg taken orally 4 times daily
Number of subjects: 10
Study: 8180726

Group type: EXPERIMENTAL
Intervention: ACE-inhibitors (enalapril and lisinopril)
Number of subjects: 6600

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (isradipine and felodipine)
Number of subjects: 6600

Group type: COMPARATOR
Intervention: Beta-blockers and/or diuretics
Number of subjects: 6600
Study: 3540872

Group type: EXPERIMENTAL
Intervention: Zomepirac 100 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Meperidine 100 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Meperidine 50 mg
Number of subjects: 88
Study: 31720808

Group type: EXPERIMENTAL
Intervention: Expiratory Muscle Training (EMT) + Air Stacking (AS)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Expiratory Muscle Training (EMT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (fixed resistance EMT)
Number of subjects: 33
Study: 29948585

Group type: EXPERIMENTAL
Intervention: Proliferative scar group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 26840653

Group type: EXPERIMENTAL
Intervention: Infliximab therapy
Number of subjects: 26
Study: 24514432

Group type: EXPERIMENTAL
Intervention: Unbalanced crystalloid (chloride: 155.5 mmol/l)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Balanced crystalloid and balanced colloid (6% w/v hydroxyethyl starch 130/0.42; chloride: 98 and 112 mmol/l)
Number of subjects: 40
Study: 22953991

Group type: COMPARATOR
Intervention: 30 mCi 131I alone (Group A)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 30 mCi 131I plus lithium 900 mg/day for 7 days (Group B)
Number of subjects: 61
Study: 21106618

Group type: EXPERIMENTAL
Intervention: Integrated motivational interviewing and cognitive behavioural therapy plus standard care
Number of subjects: 327

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 327
Study: 18366445

Group type: EXPERIMENTAL
Intervention: Nevirapine-containing combination antiretroviral therapy (NcART)
Number of subjects: 410
Study: 15695788

Group type: EXPERIMENTAL
Intervention: Intravenous iodinated contrast agent (used in part I and part II)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Non-contrast PET scan (used in part I)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Limited plain CT scan followed by WB intravenous contrast CT scan (used in part II)
Number of subjects: 54
Study: 12642963

Group type: EXPERIMENTAL
Intervention: Sugar-coated tablet (50 mg opipramol-2HCl)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Aqueous solution (50 mg opipramol-2HCl)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Film-coated tablet (100 mg opipramol-2HCl)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sugar-coated tablet (100 mg opipramol-2HCl)
Number of subjects: 38
Study: 11220871

Group type: EXPERIMENTAL
Intervention: Grandaxine in combination with standard therapy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 59
Study: 8641115

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg day‐1
Number of subjects: 62

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 62
Study: 30610915

Group type: EXPERIMENTAL
Intervention: 24 Gy in 12 fractions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 26.4 Gy in 12 fractions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30.8 Gy in 14 fractions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 12
Study: 30185008

Group type: EXPERIMENTAL
Intervention: Anterior segmental decompression
Number of subjects: 84

Group type: COMPARATOR
Intervention: Posterior laminoplasty
Number of subjects: 84
Study: 25039702

Group type: EXPERIMENTAL
Intervention: Z‐track technique
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Internally rotated foot technique
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard injection technique
Number of subjects: 75
Study: 24729586

Group type: EXPERIMENTAL
Intervention: CYP2A6 -48T→G polymorphism
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: UGT2B7 735 G/G homozygosity
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: CYP2A6 -48T→G and UGT2B7 735 G/G homozygosity (multivariable model)
Number of subjects: 84
Study: 22335390

Group type: EXPERIMENTAL
Intervention: DEX 0.5 μg/kg in 10 mL isotonic saline
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: DEX 1 μg/kg in 10 mL isotonic saline
Number of subjects: 300

Group type: COMPARATOR
Intervention: 10 mL isotonic saline (control group)
Number of subjects: 300
Study: 18476416

Group type: EXPERIMENTAL
Intervention: Acupuncture-general anesthesia (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia (Group A)
Number of subjects: 60
Study: 16642609

Group type: EXPERIMENTAL
Intervention: Combined treatment group (acupuncture + Xingnaojing injection)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Xingnaojing group
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Routine treatment group
Number of subjects: 125
Study: 14600850

Group type: EXPERIMENTAL
Intervention: Acupuncture at GV 20 and ST 36 bilaterally
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 61
Study: 10742438

Group type: EXPERIMENTAL
Intervention: 20 units of avicatonin intramuscularly injected once a week for 4 consecutive weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Inactive placebo intramuscularly injected once a week for 4 consecutive weeks
Number of subjects: 18
Study: 9181206

Group type: EXPERIMENTAL
Intervention: Automated telephone reminders
Number of subjects: 701

Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 701
Study: 1584592

Group type: EXPERIMENTAL
Intervention: Topical lidocaine (5 ml of 2% lidocaine)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline (5 ml saline)
Number of subjects: 14
Study: 4037063

Group type: EXPERIMENTAL
Intervention: Bausch and Lomb IVEX (Integrated Vision Examination System)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional clinical refraction
Number of subjects: 40
Study: 29534465

Group type: EXPERIMENTAL
Intervention: Protein supplement (whey isolate and beef hydrolysate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Maltodextrin (control)
Number of subjects: 12
Study: 27586071

Group type: EXPERIMENTAL
Intervention: PATHS curriculum
Number of subjects: 4516

Group type: COMPARATOR
Intervention: Usual provision (control)
Number of subjects: 4516
Study: 25178668

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose)
Number of subjects: 92
Study: 22235888

Group type: EXPERIMENTAL
Intervention: Gel containing niosomes entrapped with rice bran bioactive compounds
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cream containing niosomes entrapped with rice bran bioactive compounds
Number of subjects: 30

Group type: COMPARATOR
Intervention: Closed patch test on shaved rabbit skin
Number of subjects: 30